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A b s tra c t
Requirements about the quality of clinical guidelines can be represented by schem ata 
borrowed from the theory of abductive diagnosis, using tem poral logic to  model the time- 
oriented aspects expressed in a guideline. Previously, we have shown th a t these require­
ments can be verified using interactive theorem  proving techniques. In this paper, we 
investigate how this approach can be m apped to  the facilities of a resolution-based the­
orem prover, OTTER, and a com plem entary program  th a t searches for finite models of 
first-order statem ents, MACE-2. It is shown th a t the reasoning required for checking the 
quality of a guideline can be m apped to  such fully autom ated theorem-proving facilities. 
The medical quality of an actual guideline concerning diabetes mellitus 2 is investigated 
in this way.
K E Y W O R D S :  autom ated reasoning, clinical guideline, tem poral logic, abduction
1 In tro d u c tio n
Health-care is becoming more and more complicated at an astonishing rate. On the 
one hand, the number of different patient management options has risen consider­
ably during the last couple of decades, whereas, on the other hand, medical doctors 
are expected to take decisions balancing benefits for the patient against financial 
costs. There is a growing trend within the medical profession to believe th a t clinical 
decision-making should be based as much as possible on sound scientific evidence; 
this has become known as evidence-based medicine (Woolf 2000). Evidence-based 
medicine has given a m ajor impetus to the development of clinical guidelines, doc­
uments offering a description of steps tha t must be taken and considerations that 
must be taken into account by health-care professionals in managing a disease in a 
patient, to avoid substandard practices or outcomes. Their general aim is to pro­
mote standards of medical care. Clinical protocols have a similar aim as clinical 
guidelines, except tha t they offer more detail, and are often local, more detailed 
version of a related clinical guideline.
Researchers in artificial intelligence (AI) have picked up on these developments by 
designing guideline modelling languages, for instance PROforma (Fox and Das 2000) 
and GLIF3 (Peleg et al. 2000) tha t may be useful in developing computer-based 
representations of guidelines. Some of them, for example in the Asgaard project 
(Shahar et al. 1998), in the CREDO project (Fox et al. 2006) and the GLARE 
project (Terenziani et al. 2001; Terenziani et al. 2003), are also involved in the de­
sign of tools tha t support the deployment of clinical guidelines. These languages and 
tools have been evolving since the 1990s, a process tha t is gaining momentum due 
to the increased interest in guidelines within the medical community. AI researchers 
see guidelines as good real-world examples of highly structured, systematic docu­
ments tha t are amenable to formalisation.
Compared to the amount of work tha t has been put into the formalisation of 
clinical guidelines, verification of guidelines has received relatively little attention. 
In (Shiffman and Greenes 1994), logic was used to check whether a set of rec­
ommendations is complete, to find out whether or not the recommendations are 
logically consistent, and to recognise ambiguous rules if they are present. Check­
ing the consistency of temporal scheduling constraints has also been investigated 
(Duftschmid et al. 2002). Most of the work done in the area of formal verification 
of clinical guidelines, i.e., proving correctness properties using formal methods, is 
of more recent years, e.g., as done in the Protocure project 1 with the use of inter­
active theorem proving (Hommersom et al. 2007; Ten Teije et al. 2006) and model 
checking (Baumler et al. 2006; Groot et al. 2007).
This paper explores the use of automated deduction for the verification of clinical 
guidelines. For the rapid development of good quality guidelines it is required that 
guidelines can be at least partially verified automatically; unfortunately, as of yet, 
there are no verification methods tha t can be readily used by guideline developers. 
Previously, it was shown tha t for reasoning about models of medical knowledge, 
for example in the context of medical expert systems (Lucas 1993), classical auto­
m ated reasoning techniques (e.g., (Robinson 1965; Wos et al. 1984)) are a practical 
option. Im portant for the reasoning about knowledge in clinical guidelines is its 
temporal nature; time plays a part in the physiological mechanisms as well as in 
the exploration of treatm ent plans. As far as we know, the application of autom ated 
reasoning techniques to guideline knowledge has as yet not been investigated. The 
guideline we studied to this purpose has a structure similar to other guidelines and 
the verification principles used have sufficient generality. Thus, the results of the 
study go beyond the actual guideline studied.
There are two approaches to checking the quality of clinical guidelines using for­
mal methods: (1) the object-level approach amounts to translating a guideline to 
a formal language, such as Asbru (Shahar et al. 1998), and subsequently apply­
ing program verification or logical methods to analyse the resulting representation 
for establishing whether certain domain-specific properties hold; (2 ) the meta-level 
approach, which consists of formalising general requirements to which a guideline
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should comply, and then investigating whether this is the case. Here we are con­
cerned with the meta-level approach to guideline-quality checking. For example, a 
good-quality clinical guideline regarding treatm ent of a disorder should preclude 
the prescription of redundant drugs, or advise against the prescription of treatm ent 
th a t is less effective than some alternative. An additional goal of this paper is to 
establish how feasible it is to implement such meta-reasoning techniques in exist­
ing tools for autom ated deduction for the purpose of quality checking of a clinical 
guideline.
Previously, we have shown tha t the theory of abductive diagnosis can be taken 
as a foundation for the formalisation of quality criteria of a clinical guideline 
(Lucas 2003) and tha t these can be verified using (interactive) program verifica­
tion techniques (Hommersom et al. 2007). In this paper, we provide an alternative 
to this approach by translating this formalism, a restricted part of temporal logic, 
to standard first-order logic. Furthermore, the quality criteria are interpreted in 
such a way tha t they can be stated in terms of a monotonic entailment relation. We 
show that, because of the restricted language needed for the formalisation of the 
guideline knowledge, the translation is a relatively simple fragment of first-order 
logic which is amended to autom ated verification. Thus, we show tha t it is indeed 
possible, while not easy, to cover the route from informal medical knowledge to a 
logical formalisation and autom ated verification.
The meta-level approach th a t is used here is particularly im portant for the design 
of clinical guidelines, because it corresponds to a type of reasoning tha t occurs dur­
ing the guideline development process. Clearly, quality checks are useful during this 
process; however, the design of a guideline can be seen as a very complex process 
where formulation of knowledge and construction of conclusions and corresponding 
recommendations are intermingled. This makes it cumbersome to do interactive 
verification of hypotheses concerning the optimal recommendation during the con­
struction of such a guideline, because guideline developers do not generally have 
the necessary background in formal methods to construct such proofs interactively. 
Automated theorem proving could therefore be potentially more beneficial for sup­
porting the guideline development process.
The paper is organised as follows. In the next section, we start by explaining 
what clinical guidelines are, and a method for formalising guidelines by temporal 
logic is briefly reviewed. In Section 3 the formalisation of guideline quality using a 
meta-level scheme th a t comes from the theory of abductive diagnosis is described. 
The guideline on the management of diabetes mellitus type 2 tha t has been used 
in the case study is given attention in Section 4, and a formalisation of this is given 
as well. An approach to checking the quality of this guideline using the reasoning 
machinery offered by autom ated reasoning tools is presented in Section 5. Finally, 
Section 6 discusses what has been achieved, and the advantages and limitations of 
this approach are brought into perspective. In particular, we will discuss the role 
of autom ated reasoning in quality checking guidelines in comparison to alternative 
techniques such as model checking and interactive verification.
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•  Step 1: diet
•  Step 2: if Quetelet Index (QI) <  27, prescribe a sulfonylurea drug; otherwise, pre­
scribe a biguanide drug
• Step 3: combine a sulfonylurea drug and biguanide (replace one of these by a a- 
glucosidase inhibitor if side-effects occur)
•  Step 4: one of the following:
—  oral anti-diabetics and insulin
—  only insulin
Fig. 1. Tiny fragment of a clinical guideline on the management of diabetes mellitus 
type 2. If one of the steps s where s =  1, 2, 3 is ineffective, the management moves 
to step s +  1 .
2 F ram ew o rk
In this section, we review the basics about clinical guidelines and the temporal logic 
used in the remainder of the paper.
2.1 Clinical G uidelines
A clinical guideline is a structured document, containing detailed advice on the 
management of a particular disorder or group of disorders, aimed at health-care 
professionals. As modern guidelines are based on scientific evidence, they contain 
information about the quality of the evidence on which particular statements are 
based; e.g., statem ents at the highest recommendation level are usually obtained 
from randomised clinical trials (Woolf 2000).
The design of a clinical guideline is far from easy. Firstly, the gathering and clas­
sification of the scientific evidence underlying and justifying the recommendations 
mentioned in a guideline are time consuming, and require considerable expertise 
of the medical field concerned. Secondly, clinical guidelines are very detailed, and 
making sure tha t all the information contained in the guideline is complete for the 
guideline’s purpose, and based on sound medical principles is hard work.
An example of a part of a guideline is the following (translated) text:
1. refer to  a dietist; check blood glucose after 3 months
2. in case (1) fails and Quetelet Index (QI) <  27, then adm inister a sulfonylureum 
derivate (e.g. tolbutam ide, 500 mg 1 tim e per day, max. 1000 mg 2 per day) and in case of 
Quetelet Index (QI) >  27 biguanide (500 mg 1 per day, max. 1000 mg 3 tim es per day); 
s ta rt w ith lowest dosage, increase each 2-4 weeks if necessary
It is part of a real-world guideline for general practitioners about the treatm ent of 
diabetes mellitus type 2. Part of this description includes details about dosage of 
drugs at specific time periods. As we want to reason about the general structure of 
the guideline, rather than about dosages or specific time periods, we have made an 
abstraction as shown in Fig. 1. This guideline fragment is used in this paper as a 
running example.
Guidelines can be as large as 100 pages; however, the number of recommenda­
tions they include are typically few. In complicated diseases, each type of disease
is typically described in different sections of a guideline, which provides ways to 
modularise the formalisation in a natural fashion. For example, in the Protocure 
project, we have formalised an extensive guideline about breast cancer treatment, 
which includes recommendations very similar in nature and structure to the ab­
straction shown in Fig. 1. In this sense, the fragment in Fig. 1 can be lookup upon 
as one of the recommendations in any guideline whatever its size. Clinical protocols 
are normally more detailed, and the abstraction used here will not be appropriate 
if one wishes to  consider such details in the verification process. For example, in 
the Protocure project we also carried out work on the verification of a clinical pro­
tocol about the management of neonatal jaundice, where we focussed on the levels 
of a substance in the blood (bilirubin) (Ten Teije et al. 2006). Clearly, in this case 
abstracting away from substance levels would be inappropriate.
The conclusions th a t can be reached by the rest of the paper are relative to the 
abstraction tha t was chosen. The logical methods tha t we employ are related to 
this level of abstraction, even though other logical methods are available to deal 
issues such as more detailed temporal reasoning (Moszkowski 1985) or probabil­
ities (Richardson and Domingos 2006; Kersting and De Raedt 2000), which might 
be necessary for some guidelines or protocols. Nonetheless, where development of 
an abstraction of a medical document will be necessary for any verification task, 
the way it is done is dependent on what is being verified and the nature of the 
document. The level of abstraction tha t we employ allow us to reason about the 
structure and effects of treatm ents, which, in our view, is the most im portant aspect 
of many guidelines.
One way to use formal methods in the context of guidelines is to autom ati­
cally verify whether or not a clinical guideline fulfils particular properties, such as 
whether it complies with quality indicators as proposed by health-care profession­
als (Marcos et al. 2002). For example, using particular patient assumptions such as 
th a t after treatm ent the levels of a substance are dangerously high or low, it is pos­
sible to check whether this situation does or does not violate the guideline. However, 
verifying the effects of treatm ent as well as examining whether a developed clinical 
guideline complies with global criteria, such as th a t it avoids the prescription of re­
dundant drugs, or the request of tests tha t are superfluous, is difficult to impossible 
if only the guideline text is available. Thus, the capability to check whether a guide­
line fulfils particular medical objectives may require the availability of more medical 
knowledge than is actually specified in a clinical guideline. How much additional 
knowledge is required may vary from guideline to guideline. In the development of 
the theory below it is assumed th a t at least some medical background knowledge is 
required; the extent and the purpose of tha t background knowledge is subsequently 
established using the diabetes mellitus type 2 guideline. The development, logical 
implementation, and evaluation of a formal method th a t supports this process is 
the topic of the remainder of the paper.
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Table 1. Used temporal operators; t stands for a time instance.
N o ta t io n In fo rm a l m e a n in g F o rm a l m e a n in g
Hp p  has always been true  in the past t  N Hp iff Vt' <  t : t ' N p
p  U ^ p  is true until ^  holds N p  U ^  iff 3 t' >  t  : i ' N ^
and Vt'' : t  <  t ' ' <  t ' ^  t ' ' N p
2 .2  Using Temporal Logic in  Clinical G uidelines
Many representation languages for formalising and reasoning about medical knowl­
edge have been proposed, e.g., predicate logic (Lucas 1993), (heuristic) rule-based 
systems (Shortliffe 1974), and causal representations (Patil 1981). It is not uncom­
mon to abstract from time in these representations; however, as medical manage­
ment is very much a time-oriented process, guidelines should be looked upon in a 
temporal setting. It has been shown previously tha t the step-wise, possibly iterative, 
execution of a guideline, such as the example in Fig. 1, can be described precisely 
by means of temporal logic (Ten Teije et al. 2006). In a more practical setting it 
is useful to support the modelling process by means of tools. There is promising 
research for maintaining a logical knowledge base in the context of the semantic 
web (e.g., the Protege-OWL editor2), and the logical formalisation described in this 
paper could profit from the availability of such tools.
The temporal logic tha t we use here is a modal logic, where relationships between 
worlds in the usual possible-world semantics of modal logic is understood as time 
order, i.e., formulae are interpreted in a temporal frame F  =  (T, <, I ), where T is 
the set of intervals or time points, < a time ordering, and I  an interpretation of the 
language elements with respect to T and <. The language of first-order logic, with 
equality and unique names assumption, is augmented with the operators U, H, G, P, 
and F, where the temporal semantics of the first two operators is defined in Table 1. 
The last four operators are simply defined in terms of the first two operators:
N P f  ^  —I H —f  (somewhere in the past)
N F f  ^  T U f (now or somewhere in the future)
N G f ^  — F—f  (now and always in the future)
This logic offers the right abstraction level to cope with the nature of the temporal 
knowledge in clinical guidelines required for our purposes.
Other modal operators added to the language of first-order logic include X, where 
X f has the operational meaning of an execution step, followed by execution of 
program part f .  Even though this operator is not explicitly used in our formalisation 
of medical knowledge, a principle similar to the semantics of this operator is used 
in Section 5.5 for reasoning about the step-wise execution of the guideline.
In addition, axioms can be added tha t indicate tha t progression in time is linear
2 h t tp : / /p ro te g e .s ta n fo rd .e d u /o v e rv ie w /p ro te g e -o w l.h tm l  [Accessed: 21 M ay 2008]
(there are other possible axiomatisations, such as branching time, see (Turner 1985)). 
The most im portant of these are:
(1) Transitivity: N F Ff ^  F f
(2) Backward linearity: N (P f  A P0) ^  (P ( f  A 0) V P ( f  A P0) V P (P f  A 0))
(3) Forward linearity: N (F f  A F0) ^  (F (f  A 0) V F (f  A F0) V F (F f A 0))
Transitivity ensures tha t we can move along the time axis from the past into the 
future; backward and forward linearity ensure tha t the time axis does not branch. 
Consider, for example, axiom (3), which says tha t if there exists a time t when f  is 
true, and a time t ' when 0  holds, then there are three possibilities: f  and 0  hold 
at the same time, or at some time in the future f  and further away in the future 0 
hold; the meaning of the last disjunct is similar. Other useful axioms concern the 
boundedness of time; assuming tha t time has no beginning and no end, gives rise 
to the following axioms: N H f ^  P f  and N G f ^  F f .
Alternative formal languages for modelling medical knowledge are possible. For 
example, differential equations describing compartmental models tha t are used to 
predict changes in physiological variables in individual patients have been shown 
to be useful (e.g., (Magni et al. 2000; Lehmann 1998)). In the context of clinical 
reasoning they are less useful, as they essentially concern levels of substances as a 
function of time and, thus, do not offer the right level of abstraction tha t we are 
after.
3 A p p lica tio n  to  M ed ica l K now ledge
It is well-known th a t knowledge elicitation is difficult (see e.g., (Evans 1988)) and 
due to complexity and uncertainty this is particularly true for medical knowledge 
(see e.g., (van Bemmel and Musen 2002)). The effort to acquire this knowledge is 
dependent on the availability of the knowledge in the guideline and the complexity 
of the mechanisms tha t are involved in the development of the disease. For evidence- 
based guidelines, a large part of the relevant knowledge required for checking the 
quality of the recommendations is included in the guideline, which makes the prob­
lem more contained than the problem of arbitrary medical knowledge elicitation.
The purpose of a clinical guideline is to have a certain positive effect on the health 
status of a patient to which the guideline applies. To establish tha t this is indeed the 
case, knowledge concerning the normal physiology and abnormal, disease-related 
pathophysiology of a patient is required. Some of this physiological knowledge may 
be missing from the clinical guidelines; however, much of this knowledge can be 
acquired from textbooks on medical physiology, which reduces the amount of effort 
required to construct such knowledge models. The latter approach was taken in this 
research.
It is assumed tha t two types of knowledge are involved in detecting the violation 
of good medical practice:
• Knowledge concerning the (patho)physiological mechanisms underlying the 
disease, and the way treatm ent influences these mechanisms. The knowledge 
involved could be causal in nature, and is an example of object-knowledge.
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• Knowledge concerning good practice in treatm ent selection; this is meta­
knowledge.
Below we present some ideas on how such knowledge may be formalised using 
temporal logic (cf. (Lucas 1995) for earlier work in the area of formal modelling of 
medical knowledge).
We are interested in the prescription of drugs, taking into account their mode 
of action. Abstracting from the dynamics of their pharmacokinetics, this can be 
formalised in logic as follows:
(G d A r) ^  G(mi A ■ ■ ■ A mn ) (1)
where d is the name of a drug, r  is a (possibly negative or empty) requirement for the 
drug to take effect, and m k is a mode of action, such as decrease of release of glucose 
from the liver, which holds at all future times. Note tha t we assume tha t drugs are 
applied for a long period of time, here formalised as ‘always’. This is reasonable if we 
think of the models as finite structures tha t describe a somewhat longer period of 
time, allowing the drugs to take effect. Synergistic effects and interactions amongst 
drugs can also be formalised along those lines, as required by the guideline under 
consideration. This can be done either by combining their joint mode of action, by 
replacing d in the formula above by a conjunction of drugs, by defining harmful joint 
effects of drugs in terms of inconsistency, or by reasoning about modes of actions. As 
we do not require this feature for the clinical guideline considered in this paper, we 
will not go into details. In addition, it is possible to reason about such effects using 
special purpose temporal logics with abstraction and constraints, such as developed 
by Allen (Allen 1983) and Terenziani (Terenziani 2000) without a connection to a 
specific field, and by Shahar (Shahar 1997) for the field of medicine. Thus, temporal 
logics are expressive enough to cope with extensions to the formalisation as used in 
this paper.
The modes of action m k can be combined, together with an intention  n  (achieving 
normoglycaemia, i.e., normal blood glucose levels, for example), a particular patient 
condition c, and requirements rj for the modes of action to be effective:
(Gmjj A ■ ■ ■ A Gmim A r i  A ■ ■ ■ A rp A Hc) ^  Gn (2)
For example, if the mode describes tha t there is a stimulus to secrete more insulin 
and the requirement th a t sufficient capacity to provide this insulin is fulfilled, then 
the amount of glucose in the blood will decrease.
Good practice medicine can then be formalised as follows. Let B be background 
knowledge, T  C {d1, . . . ,  dp} be a set of drugs, C  a collection of patient conditions, 
R  a collection of requirements and N  a collection of intentions which the physician 
has to achieve. As an abbreviation, the union of C  and R, i.e., the variables de­
scribing the patient, will be referred to as P , i.e., P  =  CU R. Finding an acceptable 
treatm ent given such knowledge amounts to finding an explanation, in terms of a 
treatm ent, th a t the intention will be achieved. Finding the best possible explanation 
given a number of findings is called abductive reasoning (Console and Torasso 1991; 
Poole 1990). We say tha t a set of drugs T  is a treatment according to the theory of 
abductive reasoning if (Lucas 2003):
(M 1) B U GT U P  ±  (the drugs do not have contradictory effects), and 
(M 2) B U GT U P  N N  (the drugs handle all the patient problems intended to be 
managed).
One could think of the formula B U GT U P  as simulating a particular patient P  
given a particular treatm ent T . For each relevant patient groups, these properties 
can be investigated. If in addition to (M 1) and (M 2) condition
(M 3) OV(T ) holds, where Ov is a meta-predicate standing for an optimality cri­
terion or combination of optimality criteria y>, then the treatm ent is said to be 
in accordance with good-practice medicine.
A typical example of this is subset minimality Oc :
Oc (T ) =  VT' C T  : T ' is not a treatm ent according to (M 1) and (M 2) (3)
i.e., the minimum number of effective drugs are being prescribed. For example, if 
{d i,d 2,ds} is a treatm ent th a t satisfies condition (M 3) in addition to (M 1) and 
(M 2), then the subsets {d1, d2}, {d2, d3}, {d1}, and so on, do not satisfy conditions 
(M 1) and (M 2). In the context of abductive reasoning, subset minimality is often 
used in order to distinguish between various solutions; it is also referred to in 
literature as Occam’s razor. Another definition of the meta-predicate Ov is in terms 
of minimal cost Oc:
Oc(T ) =  VT', with T ' a treatment: c(T ') > c(T) (4)
where c(T) =  ^ deT cost(d); combining the two definitions also makes sense. For 
example, one could come up with a definition of Oc ,c th a t among two subset­
minimal treatm ents selects the one tha t is the cheapest in financial or ethical sense.
The quality criteria tha t we have presented in this section could also be taken as 
starting points for critiquing, i.e., criticising clinical actions performed and recorded 
by a physician (cf. (Miller 1984) for an early critiquing system), especially if we 
consider the formalisation of the background knowledge a model for simulating a 
patient receiving a specific treatm ent. However, here we look for means to criticise 
the recommendations given by the guidelines.
In order to verify the quality of guidelines, we do not make use of data from medi­
cal records. The use of such data  is especially im portant if one wishes to empirically 
evaluate the guideline. As data may be missing from the database—a very common 
situation in clinical datasets—tests ordered for a patient and treatm ents given to 
the patient may not be according to the guideline. Therefore, such datasets cannot 
be used to  identify problems with the clinical guideline. Results would tell as much 
about the dataset as about the guidelines. Once the guideline has been shown to 
be without flaws, it becomes interesting to carry out subsequent evaluation of the 
guideline using patient data. These were the main reasons why we explored guide­
line quality by using well-understood and well-described data from hypothetical 
patients; this simulates the way medical doctors would normally critically look at a 
guideline. Notice the similarity with use-cases in software engineering. This method 
is practical and possible, and could be used in the process of designing a guideline.
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4 M a n a g e m e n t o f  D ia b e te s  M ellitu s  T y p e  2
To determine the global quality of the guideline, the background knowledge itself 
was only formalised so far as required for investigating the usefulness of the theory 
of quality checking introduced above. The knowledge th a t is presented here was 
acquired with the help of a physician, though this knowledge can be found in many 
standard textbooks on physiology (e.g., (Ganong 2005; Guyton and Hall 2000)).
4.1 In it ia l  A na lysis
It is well known tha t diabetes type 2 is a very complicated disease: various metabolic 
control mechanisms are deranged and many different organ systems, such as the 
cardiovascular and renal system, may be affected by the disorder. Here we focus 
on the derangement of glucose metabolism in diabetic patients, and even tha t is 
nontrivial. To support non-expert medical doctors in the management of this com­
plicated disease in patients, access to a guideline is really essential.
One would expect tha t as this disorder is so complicated, the diabetes mellitus 
type 2 guideline is also complicated. This, however, is not the case, as may already 
be apparent from the guideline fragment shown in Fig. 1. This indicates tha t much 
of the knowledge concerning diabetes mellitus type 2 is missing from the guideline, 
and tha t without this background knowledge it will be impossible to spot the sort 
of flaws we are after. Hence, the conclusion is th a t a deeper analysis is required; 
the results of such an analysis are discussed next.
4 .2  D iabetes  Type 2 Background K now ledge
Fig. 2 summarises the most im portant mechanisms and drugs involved in the control 
of the blood level of glucose. The protein hormone insulin, which is produced by 
the B  cells in the Langerhans islets of the pancreas, has the following m ajor effects:
• it increases the uptake of glucose by the liver, where it is stored as glycogen, 
and inhibits the release of glucose from the liver;
• it increases the uptake of glucose by insulin-dependent tissues, such as muscle 
and adipose tissue.
At some stage in the natural history of diabetes mellitus type 2, the level of glucose 
in the blood is too high (hyperglycaemia) due to decreased production of insulin 
by the B cells. A popular hypothesis explaining this phenomenon is tha t target 
cells have become insulin resistant, which with a delay causes the production of 
insulin by the B cells to raise. After some time, the B cells become exhausted, and 
they are no longer capable of meeting the demands for insulin. As a consequence, 
hyperglycaemia develops.
Treatment of diabetes type 2 consists of:
• Use of sulfonylurea (SU) drugs, such as tolbutamid. These drugs stimulate 
the B cells in producing more insulin, and if the cells are not completely ex­
hausted, the hyperglycaemia can thus be reverted to normoglycaemia (normal 
blood glucose levels).
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(1) Sulfonylureas (SU)
Langerhans islets
^ m a l l rntfcsiincyc
Kpcium
Intestines
Fig. 2. Summary of drugs and mechanisms controlling the blood level of glucose; 
---------inh ib ition ,............. stimulation.
• Use of biguanides (BG), such as metformin. These drugs inhibit the release 
of glucose from the liver.
• Use of a-glucosidase inhibitors. These drugs inhibit (or delay) the absorption 
of glucose from the intestines.
• Injection of insulin. This is the ultimate, causal treatm ent.
As insulin is typically administered by injection, in contrast to the other drugs 
which are normally taken orally, doctors prefer to delay prescribing insulin as long 
as possible. Thus, the treatm ent part of the diabetes type 2 guideline mentions that 
one should start with prescribing oral antidiabetics (SU or BG, cf. Fig. l ) . Two of 
these can also be combined if taking only one has insufficient glucose-level lowering 
effect. If treatm ent is still unsatisfactory, the guideline suggests to: (l) either add 
insulin, or (2) stop with the oral antidiabetics entirely and to start with insulin.
From a medical point of view, advice (l) above is somewhat curious. If the oral 
antidiabetics are no longer effective enough, the B cells could be completely ex­
hausted. Under these circumstances, it does not make a lot of sense to prescribe 
an SU drug. The guideline here assumes that the B cells are always somewhat ac­
tive, which may limit the amount of insulin that has to be prescribed. Similarly, 
prescription of a BG (or a a-glucosidase inhibitor) is justified, as by adding such 
an oral antidiabetic to insulin, the number of necessary injections can be reduced 
from twice a day to once a day. It should be noted that, when on insulin treatm ent, 
patients run the risk of getting hypoglycaemia, which is a side effect of insulin 
treatm ent not mentioned explicitly in the guideline.
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The background knowledge concerning the (patho-)physiology of the glucose 
metabolism as described above is formalised using temporal logic, and kept as 
simple as possible. The specification is denoted by BDM2:
(1) G Drug(insulin) ^  G (uptake(liver, glucose) =  up A
uptake(peripheral-tissues, glucose) =  up)
(2) G (uptake(liver, glucose) =  up ^  release(liver, glucose) =  down)
(3) (G Drug(SU) A — capacity(b-cells, insulin) =  exhausted)
^  Gsecretion(b-cells, insulin) =  up
(4) G Drug(BG) ^  Grelease(liver, glucose) =  down
(5) (G secretion(b-cells, insulin) =  up A capacity (b-cells, insulin) =  subnorm al A
QI <  27 A H C ondition(hyperglycaem ia)) ^  G C ondition(norm oglycaem ia)
(6) (Grelease(liver, glucose) =  down A capacity(b-cells, insulin) =  subnorm al A
QI >  27 A H C ondition(hyperglycaem ia)) ^  G C ondition(norm oglycaem ia)
(7) ((Grelease(liver, glucose) =  down  V G uptake(peripheral-tissues, glucose) =  up) A
capacity(b-cells, insu lin ) =  nearly-exhausted  A Gsecretion(b-cells, insu lin ) =  up  A 
H C ondition(hyperglycaem ia)) ^  G C ondition(norm oglycaem ia)
(8) (G uptake(liver, glucose) =  up A G uptake(peripheral-tissues, glucose) =  up) A
capacity (b-cells, insulin) =  exhausted A H C ondition(hyperglycaem ia))
^  G (C ondition(norm oglycaem ia) V C ondition(hypoglycaem ia))
(9) (C ondition(norm oglycaem ia) © C ondition(hypoglycaemia) ©
C ondition(hyperglycaem ia)) A —(C ondition(norm oglycaem ia) A 
C ondition(hypoglycaemia) A Condition(hyperglycaemia))
where © stands for the exclusive OR. Note tha t when the B cells are exhausted, 
increased uptake of glucose by the tissues may result not only in normoglycaemia 
but also in hypoglycaemia. Note th a t this background knowledge was originally 
developed for reasoning about the application of a single treatm ent. It requires some 
modification in order to reason about the whole guideline fragment (see Section 5.5).
4-3  Q uality  Check
The consequences of various treatm ent options can be examined using the method 
introduced in Section 3. Hypothetical patients for whom it is the intention to reach 
a normal level of glucose in the blood (normoglycaemia) and one of the steps in the 
guideline is applicable in the guideline fragment given in Fig. l ,  are considered, for 
example:
• Consider a patient with hyperglycaemia due to nearly exhausted B cells. For 
these patients, the third step of Fig. l  is applicable, so we check that:
Bdm2 U G T  U {capacity(b-cells, insulin) =  nearly-exhausted} U 
{H Condition(hyperglycaemia)} N G Condition(normoglycaemia)
holds for T  =  {Drug(SU), Drug(BG)}, which also satisfies the minimality condition 
Oc (T ).
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Fig. 3. Translation of medical knowledge.
• Prescription of treatm ent T  =  {Drug(SU), Drug(BG), Drug(insulin)} for a 
patient with exhausted B cells, for which the intended treatm ent regime is 
described in the fourth step of Fig. l ,  yields:
Bdm2 U G T  U {capacity(b-cells, insulin) =  exhausted} U
{H Condition(hyperglycaemia)} N
G(Condition(normoglycaemia) V Condition(hypoglycaemia))
In the last case, it appears tha t it is possible tha t a patient develops hypoglycaemia 
due to treatment; if this possibility is excluded from axiom (8 ) in the background 
knowledge, then the minimality condition Oc (T ), and also Oc(T ), does not hold 
since insulin by itself is enough to reach normoglycaemia. In either case, good prac­
tice medicine is violated, which is to prescribe as few drugs as possible, taking into 
account costs and side-effects of drugs. Here, three drugs are prescribed whereas 
only two should have been prescribed (BG and insulin, assuming tha t insulin alone 
is too costly), and the possible occurrence of hypoglycaemia should have been pre­
vented.
5 A u to m a te d  Q u a lity  C heck ing
As mentioned in the introduction, we have explored the feasibility of using auto­
m ated reasoning tools to check the quality of guidelines, in the sense described 
above.
5.1 M o tiva t io n  fo r  using A u to m a ted  Reasoning
Several techniques are available for reasoning with temporal logic. Firstly, an au­
tom ated theorem prover aims at proving theorems without any interaction from 
the user. This is a problem with high complexity; e.g., for first-order logic, this 
problem is recursively enumerable. For this reason, interactive theorem proving has
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been used as an alternative, where it is possible and sometimes necessary to give 
hints to the system. As a consequence, more complicated problems can be handled; 
however, in the worst case every step of the proof has to be performed manually.
For our work, it is of interest to obtain insight how much of the proof effort can be 
autom ated as this would clearly improve the practical usefulness of employing for­
mal methods in the process of guideline development. In our previous work we have 
considered using interactive theorem proving (Hommersom et al. 2007). This was a 
successful experiment; however, the number of interactions tha t were needed were 
still high and a lot of expertise in the area of theorem proving is required for carrying 
out this task. Furthermore, there has been considerable progress in terms of speed 
and the size of problems tha t theorem provers can handle (Pelletier et al. 2002). In 
our opinion, these developments provide enough justification to explore the use of 
autom ated reasoning techniques in combination with specific strategies.
One of the most im portant application areas of model finders and theorem provers 
is program verification. In programs there is a clear beginning of the execution, 
which makes it intuitive to think about properties th a t occur after the start of 
the program. Therefore, it is not surprising tha t much work tha t has been done 
in the context of model finding and theorem proving only deals with the future 
time modality. However, it is more natural to model medical knowledge with past 
time operators, i.e., what happened to the patient in the past. It is well-known that 
formulas with a past-time modality can be mapped to a logical formula with only 
future time modalities such tha t both formulas are equivalent for some initial state 
(Gabbay l989). The main drawback of this approach is tha t formulas will get much 
larger in size (Markey 2003) and as a consequence become much harder to verify 
in a theorem prover designed for modal logics.
For this reason, we have chosen to use an alternative approach which uses a 
relational translation to map the temporal logic formulas to first-order logic. As 
primary tools we used the resolution-based theorem prover OTTER (McCune 2003) 
and the finite model searcher MACE-2 (McCune 200l), which take first-order logic 
with equality as their input. These systems have been optimised for reasoning 
with first-order logical formulas and offer various reasoning strategies to do this 
efficiently. For example, OTTER offers the set-of-support strategy and hyperres­
olution as efficient reasoning methods. There are alternative systems tha t could 
have been used; however, it is not the aim of this paper to compare these sys­
tems. OTTER has been proven to be robust and efficient, and has been successfully 
applied to solve problems of high complexity, for example in the area of algebra 
(Phillips and Vojtechovskiy 2005) and logic (Jech l995).
There has been work done to improve the speed of resolution-based theorem 
provers on modal formulas (Areces et al. 2000), but again, converse modalities such 
as the past-time operators are not considered. We found tha t the general heuristics 
applicable to full first-order logic are sufficient to our task.
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5.2  Translation
In order to prove meta-level properties, it is necessary to reason at the object-level. 
Object-level properties typically do not contain background knowledge concerning 
the validity what it being verified. For example, the (M2) property of Section 3 has 
a clear meaning in terms of clinical guidelines, which would be lost if stated as an 
object-level property. Moreover, it is not (directly) possible to state th a t something 
does not follow at the object level. Fig. 3 summarises the general approach. We will 
first give a definition for translating the object knowledge to standard logic and 
then the translation of the meta-level knowledge will follow.
5.2.1 Translation of Object Knowledge
The background knowledge, as defined in Subsection 4.2, is translated into first 
order logic. For every function f  with two elements in the co-domain, call these 
{ci, c2}, we introduce a fresh variable p for every element a in the domain such that 
f  (a) =  c1 holds iff p holds, and f  (a) =  c2 holds iff —p holds. For example, axiom
(2) of BDM2 in Section 4.2 is represented by defining ‘uptake(liver, glucose) =  up ' 
and ‘release(liver, glucose) =  up)' as propositions and rewriting this axiom as:
G(‘uptake(liver, glucose) =  up' ^  —( ‘release(liver, glucose) =  up'))
For the capacity function, a function with three elements in its co-domain, we add 
a proposition p x for each expression capacity(b-cells, insulin) =  x and an axiom 
saying th a t each pair of these propositions are mutually exclusive. Finally, the term 
QI > 27 is interpreted as a proposition as well, i.e., we do not reason about the 
numerical value of QI.
Technically, this translation is not required, since we could extend the translation 
below to full first-order temporal logic. In practice however, we would like to avoid 
additional complexity from first-order formulas during the autom ated reasoning.
The relational translation (e.g., (Moore l979; Areces et al. 2000; Schmidt and H ustadt 2003)) 
STt (^), also referred to as the standard translation, translates a propositional tem­
poral logical formula into a formula in a first-order logic with (time-indexed) 
unary predicate symbols P  for every propositional variable p and one binary pred­
icate >. It is defined as follows, where t is an individual variable standing for time:
STt(p) iff P (t)
STt(—y>) iff — STt(y>)
STt(p> A 0 ) iff STt(^) A STt (0 )
STt (Gp>) iff Vt' (t > t ' ^  STt  (y>))
STt (Hp>) iff Vt' (t > t ' ^  STt' (<£>))
Note tha t the last two elements of the definition give the meaning of the G modality 
and its converse, the H modality. For example, the formula G(p ^  Pp) translates 
to Vt2 (t > t 2 ^  (P (t2) ^  3t3 (t2 > t 3 A P ( t3))). It is straightforward to show that 
a formula in temporal logic is satisfiable if and only if its relational translation is.
Also, recall th a t we use set union to denote conjunction, thus STt ( r  U A) is defined 
as ST t(r) A STt (A).
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In the literature a functional approach to translating modal logic has appeared as 
well (Ohlbach 1988), which relies on a non-standard interpretation of modal logic 
and could be taken as an alternative to this translation.
5.2.2 Translation of Meta-level Knowledge
Again, we consider the criteria for good practice medicine and make them  suitable 
for use with the autom ated reasoning tools. In order to stress th a t we deal with 
provability in these tools, we use the ‘h ' symbol instead of the ‘ =  ' (validity) symbol.
We say tha t a treatm ent T  is a treatm ent complying with the requirements of good 
practice medicine iff:
(M 1 ') STt (BU GT U C U R) F ±
(M 2 ') STt (B U GT U C U R U — N ) h ±
(M 3 ') VT' C T  : T ' is not a treatm ent according to (M 1 ') and (M 2 ')
Criterion (M 3 ' ) is a specific instance of (M 3), i.e., subset minimality as explained 
in Section 3 (Equation (3)). As the relational translation preserves satisfiability, 
these quality requirements are equivalent to their unprimed counterparts in Section
3. To autom ate this reasoning process we use MACE-2 to verify (M 1 ' ), OTTER to 
verify (M 2 '), and (M 3 ' ) can be seen as a combination of both for all subsets of 
the given treatm ent.
5 .3  Resu lts
In this subsection we will discuss the actual implementation in OTTER and some 
results obtained by using particular heuristics.
5.3.1 Resolution Strategies
An advantage tha t one gains from using a standard theorem prover tha t a whole 
range of different resolution rules and search strategies are available and can be var­
ied depending on the problem. OTTER uses the set-of-support strategy (Wos et al. 1965) 
as a standard strategy. In this strategy the original set of clauses is divided into a 
set-of-support and a usable set such tha t in every resolution step at least one of the 
parent clauses has to be member of the set-of-support and each resulting resolvent 
is added to the set-of-support.
Looking at the structure of the formulas in Section 4, one can see tha t formulas 
are of the form p 0 A • • • A pn ^  q, where p 0 A • • • A pn and q are almost all positive 
literals. Hence, we expect the occurrence of mainly negative literals in our clauses, 
which can be exploited by using negative hyperresolution (neg_hyper for short) 
(Robinson 1965) in OTTER. W ith this strategy a clause with at least one positive 
literal is resolved with one or more clauses only containing negative literals (i.e., 
negative clauses), provided tha t the resolvent is a negative clause. The parent clause 
with at least one positive literal is called the nucleus, and the other, negative, clauses 
are referred to as the satellites.
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5.3.2 Verification of Treatments
The ordering predicate > tha t was introduced in Section 5.2.1 was defined by adding 
axioms of irreflexivity, anti-symmetry, and transitivity. We did not find any cases 
where the axiom of transitivity was required to construct the proof, which can be 
explained by the low modal depth of our formulas. As a consequence, the axiom 
was om itted with the aim to improve the speed of theorem proving. Furthermore, 
because we lack the next step modality, we did not need to axiomatise a subsequent 
time point. Experiments showed tha t this greatly reduces the amount of effort for 
the theorem prover.
We used OTTER to perform the two proofs which are instantiations of (M 2 '). 
First we, again, consider a patient with hyperglycaemia due to nearly exhausted 
B cells and prove:
STo(Bdm2 U G T  U {capacity(b-cells, insulin) =  nearly-exhausted}
U {H Condition(hyperglycaemia)}
U {—G Condition(normoglycaemia)}) h ±
where T  =  {Drug(SU), Drug(BG)}, i.e., step 3 of the guideline (see Fig. 1). Note 
th a t we use ‘0' here to  represent the current time point. This property was proven 
using OTTER in 62 resolution steps with the use of the negative hyperresolution 
strategy. A summary of this proof can be found in Appendix Appendix A.
Similarly, given T  =  {Drug(SU), Drug(BG), Drug(insulin)} to  a patient with ex­
hausted B cells, as suggested by the guideline in step 4, it follows that:
STo(Bdm2 U G T  U {capacity(b-cells, insulin) =  exhausted} U
{HCondition(hyperglycaemia)} U
{—(G(Condition(normoglycaemia) V Condition(hypoglycaemia)))}) h ±
However, if we take T  =  {Drug(insulin}, the same holds, which shows that, as 
already mentioned in Section 4.3, tha t even if we ignore the fact th a t the patient may 
develop hypoglycaemia, the treatm ent is not minimal. Compared to the previous 
property, a similar magnitude of complexity in the proof was observed, i.e., 52 
resolution steps.
5.3.3 Using Weighting
One possibility to improve the performance is by using term  ordering strategies. 
This will be explained below, but first we give a motivating example why this is 
particularly useful for this class of problems. Consider the following example taken 
from (Areces et al. 2000). Suppose we have the formula G(p ^  Fp). Proving this 
satisfiable amounts to proving th a t the following two clauses are satisfiable:
1. 0 > ti  V —P (ti)  V t i  > f  (ti)
2. 0 > t 2 V —P ( t2) V P ( f  (t2))
It can be observed, tha t although we have two possibilities to resolve these two 
clauses, for example on the P  literal, this is useless because the negative P  literal is
18 Arjen Hommersom, Peter J.F. Lucas, and Patrick van Bommel
W e ig h ts C la u se s  (b in a ry  res) C la u se s  (n e g a tiv e  h y p e r  res)
(0, 1) 17729 6994
(1, 0) 13255 6805
(1, 1) 39444 7001
(1, - 1) 13907 6836
,- 40548 7001
,- 16606 6805
,- 40356 7095
( 3 ,-5 ) 27478 7001
Fig. 4. Generated clauses to prove an instance of property M 2 ' depending on 
weights (x, y) for the ordering relation on time.
only bound by the G-operator while the positive P  literal comes from a formula at 
a deeper modal depth under the F-operator. Suppose we resolve these —P (ti)  and 
P (ƒ (t2)) and rename t 2 to  t, which generates the clause:
0 > ƒ (t) V ƒ (t) > ƒ (ƒ (t)) V 0 > t V —P (t)
and with (2 ) again we have:
0 > ƒ (ƒ (t)) V ƒ (ƒ (t)) > ƒ (ƒ (ƒ (t))) V 0 > ƒ (t) V c > t V —P (t)
etc. In this way, we can generate many new increasingly lengthy clauses. Clearly, 
these nestings of the Skolem functions will not help to find a a contradiction more 
quickly if the depth of the modalities in the formulas th a t we have is small, as 
the new clauses are similar to previous clauses, except tha t they describe a more 
complex temporal structure.
In OTTER the weight of the clauses determines which clauses are chosen from 
the set-of-support and usable list to become parents in a resolution step. In case 
the weight of two clauses is the same, there is a syntactical ordering to determine 
which clause has precedence. This is called the Knuth-Bendix Ordering (KBO) 
(Knuth and Bendix 1970). As the goal of resolution is to find an empty clause, 
lighter clauses are preferred. By default, the weight of a clause is the sum of all 
occurring symbols (i.e., all symbols have weight 1) in the literals. As we have ar­
gued, since the temporal structure of our background knowledge is relatively simple, 
nesting Skolem functions will not help to find such an empty clause. Therefore it 
can be of use to manually change the weight of the ordering symbol, which is done 
in OTTER by a tuple (x, y) for each predicate, where x is multiplied by the sum of 
the weight of its arguments and is added to y to calculate the new weight of this 
predicate. For example, if x =  2 and y =  -3 ,  then v > w has a to tal weight of 
2 +  2 — 3 = 1 ,  and ƒ (ƒ (c)) > ƒ (d) has a weight of 2 * 3 +  2 * 2 — 3 =  7.
See Fig. 4 where we show results when we applied this for some small values for 
x and y for both binary and negative hyperresolution. W hat these numbers show 
(similar results were obtained for the other property) is tha t the total weight of the 
ordering predicate should be smaller than the weight of other, unary, predicates.
Checking the Quality of Clinical Guidelines using Automated Reasoning Tools19
> : Condition(hyperglycaemia) :
t | 0 1 t 0 1
--+---
0 | F T
1 | F F
T T
Drug(SU): Drug(BG) :
t 0 1 t 0 1
F F T F
capacity(b-cells, 
t | 0 1
T T
insulin) = nearly-exhausted :
Fig. 5. Snippet from a MACE-2 generated model. It lists the tru th  value of all the 
unary predicates given each element of the domain (i.e., the time points ‘0 ’ and 
‘1 ’) and every combination of domain elements for the binary predicate <. Truth 
values are denoted by T (true) and F (false).
Possibly somewhat surprisingly, the factor x should not be increased too much. 
Furthermore, in the case of a negative hyperresolution strategy the effect is minimal.
5.4 D isproofs
MACE-2 (Models And CounterExamples) is a program tha t searches for small finite 
models of first-order statem ents using a Davis-Putman-Loveland-Logemann deci­
sion procedure (Davis and Putm an 1969; Davis et al. 1962) as its core. Because of 
the relative simplicity of our temporal formulas, it is to be expected th a t counterex­
amples can be found rapidly, exploring only few states. Hence, it could be expected 
th a t models are of the same magnitude of complexity as in the propositional case 
and this was indeed the case. In fact, the countermodels tha t MACE-2 found consist 
of only 2 elements in the domain of the model.
The first property we checked corresponded to checking whether the background 
knowledge augmented with patient data and a therapy was consistent, i.e., criterion 
Consider a patient with hyperglycaemia due to nearly exhausted B cells. 
We used MACE-2 to verify:
STo(Bdm2 U G T  U {capacity (b-cells, insulin) =  exhausted} U 
{H Condition(hyperglycaemia)}) V ±
for T  =  {Drug(SU), Drug(BG), Drug(insulin)}. From this it follows tha t there is a 
model if T  =  {Drug(SU), Drug(BG)} and consequently we have verified (M 1 ').
Similarly, we found tha t for all T  C {Drug(SU), Drug(BG)}, it holds that:
STo(Bdm2 U G T  U {capacity(b-cells, insulin) =  nearly-exhausted}
U {H Condition(hyperglycaemia)}
U {—G Condition(normoglycaemia)}) V ±
i.e., it is consistent to believe the patient will not have normoglycaemia if less 
drugs are applied, which violates (M 2) for these subsets. So indeed the conclusion 
was tha t the treatm ent complies with (M 3 ') and thus complies with the criteria of 
good practice medicine. See for example Fig. 5, which contains a small sample of the 
output tha t MACE-2 generated. The output consists of a first-order model with two 
elements in the domain, named ‘0 ’ and ‘1’, and an interpretation of all predicates 
and functions in this domain. It shows tha t it is consistent with the background 
knowledge to believe th a t the patient will continue to suffer from hyperglycaemia 
if one of the drugs is not applied. Note tha t the model specifies tha t biguanide is 
applied at the first time instance, as this is not prohibited by the assumptions.
Finally, consider the treatm ent T  =  {Drug(SU), Drug(BG), Drug(insulin)} for a 
patient with exhausted B cells, we can show that:
STo(Bdm2 U G T  U {capacity(b-cells, insulin) =  exhausted} U
{HCondition(hyperglycaemia)} U
{G(Condition(normoglycaemia)))}) V ±
so the patient may be cured with insulin treatm ent, even though this is not guaran­
teed as Condition(normoglycaemia) does not deductively follow from the premises. 
However, it is possible to prove the same property when T  =  {Drug(insulin)} and 
thus (M 3 ') does not hold in this case and as a consequence the guideline does not 
comply with the quality requirements as discussed in Section 4.3.
5.5  P lan  S tructure
So far, we have not considered the order in which treatm ents are being considered 
and executed. In this subsection, we look at the problem of reasoning about the 
order of treatm ents described in the treatm ent plan listed in Fig. 1.
5.5.1 Formalisation
In order to reason about a sequence of treatm ents, additional formalisation is re­
quired. The background knowledge was developed for reasoning about an individual 
treatm ent, and therefore, is parameterised for the treatm ent tha t is being applied. 
We postulate BDM2, parameterised by s, where s is a certain step in the protocol, 
i.e., s =  1, 2, 3, 4 (cf. Fig. 1; for example s =  1 corresponds to diet). The first axiom 
is then described by:
Vs (G Drug(insulin, s) ^  G(uptake(liver, glucose, s) =  up))
The complete description of this background knowledge is denoted by BDM2 The 
reason for this is tha t the ‘G’ modality ranges over the time period of an individ­
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ual treatm ent, rather than the complete time frame. Similarly, the patient can be 
described, assuming the description of the patient description does not change, by 
Vs P (s), where P  is a parameterised description of the patient. For example, in 
diabetes, it may be assumed th a t the Quetelet index does not change; however, the 
condition generally does change due to the application of a treatment.
The guideline as shown in Fig. 1 is modelled in two parts. First, we need to 
specify which treatm ent is administered in each step of the protocol. Second, the 
transition of one step to the next has to be specified. The former is modelled as a 
conjunction of treatm ents for each step of the guideline. For example, in the initial 
treatm ent step (i.e., step 1) only ‘d iet’ is applied, hence, the following is specified:
G diet(1)
In general, for treatm ent T(s) in step s, we write GT(s). Here s is a meta-variable 
standing for the step in the protocol, i.e., it is a ground atom in the concrete 
specification of the protocol. Object-level variables can be recognised by the fact 
th a t they are bounded by quantification. For example, T(s) is a ground term  in 
the actual specification, while Vs T(s) is not. In this notation, we will refer to 
the set of treatm ent prescriptions for each step and all patient groups P (s) as 
D =  U s P (s) -  GT(s).
The second part of the formalisation concern the change of treatments, which 
is formalised by a predicate control(s) tha t describes which step of the guideline 
will be reached. Recall from Fig. 1, tha t treatm ents are stopped in case they fail, 
i.e., when they do not result in the desired effect. This change of control can be 
described in the meta-language as:
BU G T(s) U P (s) =  N (s) ^  control(s +  1) (5)
for all steps s, i.e., if the intention cannot be deduced, then we move to a subsequent 
step. We will refer to this axiom as the control axiom C. It is not required tha t the 
control is m utually exclusive: if control(s +  1) holds, then control(s) also holds, 
although the converse is not necessarily true. Note tha t —N (s) cannot be deduced 
from the background knowledge, due to its causal nature; however, clearly, in the 
context of automatic reasoning, it is useful to reason about the theory deductively. 
To be able to do this, one can use the so-called completed theory, denoted as 
CO M P(r), where r  is some first-order theory. The COMP function is formally 
defined in (Clark 1978) for general first-order theories. For propositional theories 
one can think of this function as replacing implication with bi-implications, for 
example, COMP(p — q) =  p ^  q and COMP({p — q, p — r}) =  p  ^  (q V r). By 
the fact tha t the temporal formulas can be interpreted as first-order sentences, we 
have for example:
COMP(G Drug(insulin) — G uptake(liver, glucose) =  up)
=  G Drug(insulin) ^  G uptake(liver, glucose) =  up
This can be extended for the whole set of axioms of diabetes. The relevance of 
this operator for this chapter, is tha t abductive reasoning can be seen as deductive 
reasoning in this completed theory (Console et al. 1991). In the following section,
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we introduce an extension to this idea for the restricted part of temporal logic 
described in Section 3. These results are based on a direct application of work done 
by Stärk (Stark 1994). Then, we will apply those results to the above formalisation.
5.5.2 Completion
An im portant resolution strategy is SLD resolution which is linear resolution with 
a selection function for Horn clauses, i.e., clauses with at most one positive literal 
(for a definition see for example (Lucas and van der Gaag 1991)). SLD resolution 
is sound and refutation complete for Horn clause logic. It is refutation complete 
in the sense tha t if one would use a breadth-first strategy through the tree of all 
SLD derivations, a finite SLD refutation will be found if the set of Horn clauses is 
unsatisfiable. Below, as a convenience, we will write th a t we derive 0  from using 
SLD resolution iff there is an SLD refutation from A —0.
SLDNF resolution augments SLD resolution with a so-called ‘negation as failure’ 
(NAF) rule (Clark 1978). The idea is in order to prove —A, try  proving A; if the 
proof succeeds, then the evaluation of —A fails; otherwise, if A fails on every eval­
uation path, then —A succeeds. The latter part of this strategy is not a standard 
logical rule and could be described formally as, given some theory r ,  if r  1/ A then
r  I----A  is concluded. It must be noted tha t the query A must be grounded. This
type of inference is featured in logic programming languages such as PROLOG, al­
though most implementations also infer the negation as failure for non-ground goal 
clauses.
This type of resolution is used here to show th a t a completed theory can be used in 
a deductive setting to reason about the meta-theory. In particular, in (Stärk 1994), 
this is used to show tha t a certain class of programs have the property th a t if 
a proposition deductively follows from tha t program, then there is a successful 
SLDNF derivation. This is shown by so-called inpu t/ou tpu t specifications, which 
are given by a set of mode specifications for every predicate. A mode specifica­
tion for a predicate says which arguments are input arguments and which argu­
ments are output arguments; other arguments are called normal arguments. Given 
an input/ou tput specification a program must be written in such a way tha t in 
a computed answer the free variables of the output terms are contained in the 
free variables in the input terms. Furthermore, the free variables of a negative lit­
eral must be instantiated to ground terms during a computation. For example, the 
following well-known logic program
append([], L, L).
append(Li, L 2, L3) ^  append([X|Li], L 2, [X |L3j).
has two mode specifications. Either the first two arguments are input arguments 
resulting in a concatenation of the two lists in the output argument, or, the first 
two arguments can act as output arguments resulting in the decomposition of the 
third argument into two lists.
In the following, we will write all ground atoms without arguments, e.g., we
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denote A when we mean A(c), where c is some constant, unless the constant is 
relevant. We then prove the following lemma.
Lemma 1
If C O M P(r) =  — A g, where r  is a formula of the form:
VsVt (A0 (s) A • • • A An (s) A An+1(t, s) A • • • A Am(t, s) — A k(t, s))
where Aj are all positive atoms and A g is any ground atom, then there exists an 
SLDNF derivation of — A g for theory r .
A proof can be found in Appendix Appendix B . Note here tha t r  only contains Horn 
clauses. Further note th a t the relation between the completed theory and SLDNF 
derivation holds for a much more elaborate class of formulas (Stark 1994). Hence, 
this result could be generalised to a more elaborate temporal descriptions. However, 
the fact tha t we are dealing with Horn clauses yields the following property, which 
is the main result of this section.
Theorem 1
If r  is in the form as assumed in Lemma 1, A is again any ground atom, and it 
holds tha t C O M P(r) =  —A, then r  =  A.
Proof
Suppose C O M P(r) =  —A. Then by Lemma 1 it holds th a t —A is derived by SLDNF 
resolution from r .  From the definition of SLDNF derivation either —A holds by SLD 
resolution or a derivation for A fails. In either way, it follows from the soundness 
of SLD resolution th a t deriving A from r  using SLD resolution will fail. Since each 
of the clauses is Horn and SLD resolution is complete for these Horn clauses, it 
follows tha t T A. □
5.5.3 Implementation
The result of Theorem 1 is used to investigate the completion of a restricted subset of 
temporal logic. To simplify matters, we introduce the following assumptions. First, 
the H operator is omitted. In this case, this is justified as this operator only plays a 
role to denote the fact tha t the patient suffers from hyperglycaemia and plays no role 
in the temporal reasoning. Hence, we have a (propositional) variable tha t expresses 
exactly the fact tha t in the past the condition was hyperglycaemic. Second, as there 
is no reasoning about the past, we may translate Gp> to Vt y>(t). Finally, we only 
make a distinction between whether the glucose level is decreasing or not, i.e., we 
abstract from the difference between normo- and hypoglycaemia. Furthermore, we 
assume tha t the mutual exclusion of values for capacity is omitted and part of 
the description of the patient, i.e., a patient with QI > 27 is now described by 
{QI > 27, —(QI < 27)}. We will refer to these translation assumptions in addition 
to the translation to first-order logic described in Section 5.2.1 as ST£. Furthermore, 
let C O M P(r) be understood as the formula which is equivalent according to ST to 
C O M P(STt(r)) whenever r  is a theory in temporal logic. Note tha t this abstraction
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T e m p o ra l Logic F ir s t -o r d e r  Logic
A i A • • • A An A G An+i A Vt (Ai A • ••A An A An+iA
••• A G A m —» G A i ••• A Am —— A i(t))
G (Ai A ••• A An —— Ai) Vt (Ai (t) A •••A An (t) —— A i(t))
G A i, Ai A i(t), Ai
—G Ai —A i
Fig. 6 . The type of temporal formulas and their translation, where the Skolem 
constants describing time instances are omitted.
is sound, in the sense tha t anything tha t is proven with respect to the condition of 
the patient by the abstracted formulas can be proven from the original specification.
Let pi be a patient characteristic, d a drug, and /i either a patient characteristic 
or drug. The temporal formulas tha t are allowed are listed in Fig. 6 . We claim that 
each temporal formula is an instance of a temporal formula mentioned in Fig. 6 , 
universally quantified by a step s, except for the last goal clause which is grounded. 
The background knowledge can be written in terms of the first and second clause, 
taken into account tha t axiom (7) can be rephrased to two clauses of the first 
type and we need to make sure th a t each literal is coded as a positive atom. This 
is a standard translation procedure tha t can be done for many theories and is 
described in e.g., (Shepherdson 1987, p. 23). Axiom (3) needs to be rewritten for 
each of the cases of capacity implied by the negated sub-formula. For each drug 
and patient characteristic in the hypothesis, the third clause of Fig. 6 applies. A 
goal is an instance of the fourth clause of Fig. 6 . As the first three clauses are Horn, 
Theorem 1 can be instantiated for the background knowledge, which yields:
Theorem 2
COMP(BDM2 U GT(s) U P (s)) =  —N (s) implies BDM2 U P (s) U GT(s) =  N (s).
This states that, if the completed theory implies tha t the patient will not have 
normoglycaemia, then this is consistent conclusion with respect to the original 
specification, for any specific step described by s. Therefore, there is no reason to 
assume th a t T  is the correct treatm ent in step s. This result is applied to the control 
axiom C as described in Section 5.5.1, i.e., formula 5. If we were to deduce that
COMP(B U G T(s) U P (s)) =  —N (s)
then, assuming the literals are in a proper form required by Theorem 2, this implies 
that
BU G T(s) U P (s) =  N (s)
Thus, we postulate the following axiom describing the change of control, denoted 
by C'
COMP(B A G T(s) A P (s)) A —N (s) — contro/(s +  1)
The axioms D (cf. Section 5.5.1) and C' are added to the guideline formalisation in 
order to reason about the structure of the guideline.
To investigate the quality of the treatm ent sequence, a choice of quality criteria 
has to be chosen. Similarly to individual treatments, notions of optimality could be 
studied. Here, we investigate the property th a t for each patient group, the intention 
should be reached at some point in the guideline. For the diabetes guideline, this 
is formalised as follows:
BD m2 U D U Vs P  (s) =  3s N  (s)
As we restrict ourselves to a particular treatm ent described in step s, this property 
is similar to  the property proven in Section 5.3. However, it is possible tha t the 
control never reaches s for a certain patient group, hence, using the knowledge 
described in C, it is also im portant to verify tha t this step is indeed reachable, i.e.,
BD m2 U D U Vs P  (s)) UC7 =  3s (N  (s) A control(s))
The above was used to verify a number of properties for different patient groups. 
For example, assume
P (s) =  {capacity(liver, glucose, s) =  exhausted, QI(s) < 27,
H Condition(normoglycaemia)}
(note the H operator is abstracted from the specification) then:
BD m2 U D U Vs P  (s) U C1 =  G Condition( normoglycaemia, 3) A control(3)
i.e., the third step will be reached and in this step the patient will be cured. This was 
implemented in O T T E R  using the translation as discussed in the previous subsection. 
As the temporal reasoning is easier due to the abstraction tha t was made, the proofs 
are reasonably short. For example, in the example above, the proof has length 25 
and was found immediately.
6 C o nclusions
The quality of guideline design is for the largest part based on its compliance with 
specific treatm ent aims and global requirements. We have made use of a logical 
meta-level characterisation of such requirements, and with respect to the require­
ments use was made of the theory of abductive, diagnostic reasoning, i.e., to diag­
nose potential problems with a guideline (Lucas 1997; Lucas 2003; Poole 1990). In 
particular, what was diagnosed were problems in the relationship between medical 
knowledge, and suggested treatm ent actions in the guideline text and treatm ent ef­
fects; this is different from traditional abductive diagnosis, where observed findings 
are explained in terms of diagnostic hypotheses. This method allowed us to examine 
fragments of a guideline and to prove properties of those fragments. Furthermore, 
we have succeeded in proving a property using the structure of the guideline, namely 
th a t the blood glucose will go down eventually for all patients if the guideline is 
followed (however, patients run the risk of developing hypoglycaemia).
In earlier work (Hommersom et al. 2007), we used a tool for interactive program 
verification, named KIV (Reif 1995), for the purpose of quality checking of the di­
abetes type 2 guideline. Here, the main advantage of the use of interactive theorem
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proving was tha t the resulting proofs were relatively elegant as compared to the 
solutions obtained by autom ated resolution-based theorem proving. This may be 
im portant if one wishes to convince the medical community th a t a guideline com­
plies with their medical quality requirements and to promote the implementation 
of such a guideline. However, to support the design of guidelines, this argument is 
of less importance. A push-button technique would there be more appropriate. The 
work tha t needs to be done to construct a proof in an interactive theorem prover 
would severely slow down the development process as people with specialised knowl­
edge are required.
Another method for verification tha t is potentially useful is model checking. One 
advantage is tha t it allows the end user, in some cases, to inspect counter example 
if it turns out th a t tha t a certain quality requirement does not hold. The main 
disadvantage is tha t the domain knowledge as we have used here is not obviously 
represented into a automaton, as knowledge stated in linear temporal logic usually 
cannot succinctly be translated to such a model.
One of the main challenges remains bridging the gap between guideline devel­
opers and formal knowledge needed for verification. The practical use of the work 
th a t is presented here depends on such developments, although there are several 
signs th a t these developments will occur in the near future. Advances in this area 
have been made in for example visualisation (Kosara and Miksch 2001) and in­
teractive execution of guideline representation languages. Furthermore, the repre­
sentation tha t we have used in this paper is conceptually relatively simple com­
pared to representation of guidelines and complex temporal knowledge discussed 
in for example (Shahar and Cheng 2000), however, in principle all these mecha­
nisms could be formalised in first-order logic and could be incorporated in this 
approach. Similarly, probabilities have been ignored in this paper, for which several 
probabilistic logics tha t have been proposed in the last couple of years seem appli­
cable in this area (Richardson and Domingos 2006; Kersting and De Raedt 2000). 
Exploring other types of analysis, including quantitative and statistical, could have 
considerable impact, as we are currently moving into an era where guidelines are 
evolving into highly structured documents and are constructed more and more us­
ing information technology. It is not unlikely tha t the knowledge itself will be stored 
using a more formal language. Methods for assisting guideline developers looking 
into the quality of clinical guidelines, for example, using autom ated verification will 
then be useful.
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A p p e n d ix  A  P ro o f  o f M eta -lev e l P ro p e r ty  (M 2)
In the formulas below, each literal is augmented with a time-index. These implicitly 
universally quantified variables are denoted as t and t 7. Recall tha t g(x, y) =  down
is implemented as — (g(x, y) =  up) and functions f  and f 7 are Skolem functions 
introduced by OTTER. Both Skolem functions map a time point to a later time 
point. Consider the following clauses in the usable and set-of-support list:
2 capacity(b-cells, insulin, t) =  nearly-exhausted V 
capacity(b-cells, insulin, t) =  exhausted
14 t > f  (t) V capacity(b-cells, insulin, t) =  exhausted V t > t 7 V 
secretion(b-cells, insulin, t 7) =  up
15 — Drug(SU, f  (t)) V capacity(b-cells, insulin, t) =  exhausted V t > t 7 V 
secretion(b-cells, insulin, t 7) =  up
51 0 > t V Drug(SU, t)
53 capacity(b-cells, insulin, 0) =  nearly-exhausted
For example, assumption (53) models the capacity of the B cells, i.e., nearly ex­
hausted at time 0 where the property as shown above should be refuted. Note 
th a t some of the clauses are introduced in the translation to propositional logic, 
for example assumption (2) is due to the fact tha t tha t values of the capacity are 
m utually exclusive. This is consistent with the original formalisation, as functions 
map to unique elements for element of the domain.
Early in the proof, O T T E R  deduced tha t if the capacity of insulin in B cells is 
nearly-exhausted, then it is not completely exhausted:
56 [negJiyper ,5 3 ,2 ] capacity(b-cells, insulin, 0) ^  exhausted
Now we skip a part of the proof, which results in information about the relation 
between the capacity of insulin and the secretion of insulin in B cells at a certain 
time point:
517 [n eg J iy p e r,516,53] 0 ^  / /(0)
765 [n eg Jiy p e r,761 ,50 ,675]
capacity(b-cells, insulin, f  7(0)) =  nearly-exhausted V 
secretion(b-cells, insulin, f 7(0 )) =  down
This information allows O T T E R  to quickly complete the proof, by combining it 
with the information about the effects of a sulfonylurea drug:
766 [n e g J iy p e r,765 ,15 ,56 ,517]
capacity (b-cells, insulin, f  (0)) =  nearly-exhausted V 
—D rug(SU ,f 7(0))
767 [n e g J iy p e r,765 ,14 ,56 ,517]
capacity (b-cells, insulin, f  (0)) =  nearly-exhausted V
0 > f  (0 )
after which (53) can be used as a nucleus to yield:
768 [n eg J iy p e r,767,53] 0 ^  /i(0 )
and consequently by taking (51) as a nucleus, we find th a t at time point 0 the 
capacity of insulin is not nearly exhausted:
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769 [n eg J iy p e r,768 ,51 ,766]
capacity(b-cells, insulin , 0 ) =  nearly-exhausted
This directly contradicts one of the assumptions and this results in an empty clause:
770 [b in a ry ,7 6 9 .1 ,5 3 .1 ]  ±
A p p e n d ix  B P ro o f  o f L em m a 1
Let r  and n  denote lists of literals. An n-tuple ( x i , . . . , x n ) G {in, out, normal}” 
is called a mode specification for an n-place relation symbol R G Rel, denoted by 
a , ß, 7 . The set of input variables of the atom R (t1, . . . ,  t n) (where t j is a term) 
given a mode specification is defined by:
in (R (ti, . . . ,  t” ), (xi, . . . ,  X” )) =  |^J{vars(tj) | 1 < i < n, xj =  in}.
Analogously, the set of output variables is given by
out(R (ti, . . . ,  t” ), (xi, .. ., X” )) =  |^J{vars(tj) | 1 < i < n, xj =  out}.
An inpu t/ou tpu t specification is a function S which assigns to every n-place relation 
symbol R a set S + (R /n ) C {in, out, normal}” of positive mode specification and a 
set S - (R /n) C {in, normal}” of negative mode specifications for R.
D efinition 1 (D efinition 2.1 (Stärk 1994))
A clause n  ^  A is called correct with respect to an inpu t/ou tpu t specification S 
or S-correct iff
(C 1) for all positive modes a  G S + (A) there exists a perm utation of the literals of 
the body n  of the form B i , . . . ,  Bm, —C i , . . .  — C” and for all 1 < i < m a positive 
mode ßj G S +(B j ) such tha t
• for all 1 < i < m, in(B j , ßj ) C in(A, a) U |J i< j< j ou t(B j, ß j ),
• out (A, a ) C in(A, a) U U i<j<m °u t(B j, ß j ),
• for all 1 < i < n,
S - (Cj) =  0  and vars(C j) C in(A, a) U U i<j<m ou t(B j, ß j ),
(C 2) for all negative modes a  G S (A) for all positive literals B  of n  there exists 
a negative mode ß  G S - (B) with in(B , ß) C in(A, a) and for all negative literals 
—C of n  there exists a positive mode 7  G S + (C ) with in(C, 7 ) C in(A, a).
A program P  is called correct with respect to an input/ou tput specification S iff 
all clauses of P  are S-correct.
D efinition 2 (D efinition 2.2 (Stärk 1994))
A goal r  is called correct with respect to an input/ou tput specification S or S- 
correct iff there exists a perm utation B i , . . . ,  Bm, —Ci , . . .  — C”  of the literals of r  
and for all 1 < i < m a positive mode ßj G S +(B j ) such that
(G 1) for all 1 < i < m, in (B j , ßj ) C U i <j<j ou t(B j, ß j ),
(G 2) for all 1 < i < m, S (Cj ) =  0  and vars(C j) C U i< j< m ou t(B j, ß j ).
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Theorem 3 (reformulation o f Theorem 5.4 (Stark 1994))
Let P  be a normal program which is correct with respect to the input/output 
specification S and let L i , . . . ,  Lr be a goal.
(a) If C O M P(P) =  L 1 A . . .  A lr and L 1, . . . ,  Lr is correct with respect to S then 
there exists a substitution 0 such th a t there is a successful SLDNF derivation for 
L 1, . . . ,  Lr with answer 0. (...)
Define S+ =  S -  =  {(normal} for every unary predicate and {(normal, normal)} 
for every binary predicate. Observe tha t r  contains only definite clauses, so each 
condition in Definition 1 is trivially satisfied, thus r  is S-correct. Similarly, as the 
goal 0  is definite, all clauses of Definition 2 are trivially satisfied, thus also S- 
correct. Hence, by Theorem 3, we find th a t there is a successful SLDNF derivation 
of 0  given r .
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